Cargando…
Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
Mycobacterium avium complex pulmonary disease (MAC-PD) requires long-term treatment. We analyzed the outcomes of 992 MAC-PD patients according to disease severity and compared the outcomes of intermittent and daily therapy for mild disease. Patients were divided into groups according to severity usi...
Autores principales: | Kim, Bo-Guen, Jhun, Byung Woo, Kim, Hojoong, Kwon, O Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816953/ https://www.ncbi.nlm.nih.gov/pubmed/35121809 http://dx.doi.org/10.1038/s41598-022-06022-z |
Ejemplares similares
-
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020) -
Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Zo, Sungmin, et al.
Publicado: (2022) -
Spontaneous Cultural Conversion Rate of Mycobacterium avium Complex Pulmonary Disease Based on BACES Severity
por: Kim, Bo-Guen, et al.
Publicado: (2023) -
Characteristics of Circulating CD4(+) T Cell Subsets in Patients with Mycobacterium avium Complex Pulmonary Disease
por: Han, Sun Ae, et al.
Publicado: (2020) -
Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)